[HTML] plos.org

[HTML][HTML] Celecoxib ameliorates portal hypertension of the cirrhotic rats through the dual inhibitory effects on the intrahepatic fibrosis and angiogenesis

JH Gao, SL Wen, WJ Yang, YY Lu, H Tong, ZY Huang… - PloS one, 2013 - journals.plos.org
Background Increased intra-hepatic resistance to portal blood flow is the primary factor
leading to portal hypertension in cirrhosis. Up-regulated expression of cyclooxygenase-2 …
被引用次数：62 相关文章
[HTML] nih.gov

[HTML][HTML] Celecoxib Ameliorates Portal Hypertension of the Cirrhotic Rats through the Dual Inhibitory Effects on the Intrahepatic Fibrosis and Angiogenesis

JH Gao, SL Wen, WJ Yang, YY Lu, H Tong, ZY Huang… - PLoS ONE, 2013 - ncbi.nlm.nih.gov
Background Increased intra-hepatic resistance to portal blood flow is the primary factor
leading to portal hypertension in cirrhosis. Up-regulated expression of cyclooxygenase-2 …

Celecoxib ameliorates portal hypertension of the cirrhotic rats through the dual inhibitory effects on the intrahepatic fibrosis and angiogenesis.

JH Gao, SL Wen, WJ Yang, YY Lu, H Tong, ZY Huang… - Plos one, 2013 - europepmc.org
Background Increased intra-hepatic resistance to portal blood flow is the primary factor
leading to portal hypertension in cirrhosis. Up-regulated expression of cyclooxygenase-2 …
[PDF] semanticscholar.org

[PDF][PDF] Celecoxib Ameliorates Portal Hypertension of the Cirrhotic Rats through the Dual Inhibitory

JH Gao, SL Wen, WJ Yang, YY Lu, H Tong - 2013 - pdfs.semanticscholar.org
Background: Increased intra-hepatic resistance to portal blood flow is the primary factor
leading to portal hypertension in cirrhosis. Up-regulated expression of cyclooxygenase-2 …

[引用][C] Celecoxib Ameliorates Portal Hypertension of the Cirrhotic Rats through the Dual Inhibitory Effects on the Intrahepatic Fibrosis and Angiogenesis

JH Gao, SL Wen, WJ Yang, YY Lu, H Tong, ZY Huang… - PLoS ONE, 2013 - cir.nii.ac.jp
Celecoxib Ameliorates Portal Hypertension of the Cirrhotic Rats through the Dual Inhibitory
Effects on the Intrahepatic Fibrosis and Angiogenesis | CiNii Research CiNii 国立情報学研究所 …
[PDF] scienceopen.com

[PDF][PDF] Celecoxib Ameliorates Portal Hypertension of the Cirrhotic Rats through the Dual Inhibitory

JH Gao, SL Wen, WJ Yang, YY Lu, H Tong - 2013 - scienceopen.com
Background: Increased intra-hepatic resistance to portal blood flow is the primary factor
leading to portal hypertension in cirrhosis. Up-regulated expression of cyclooxygenase-2 …

[引用][C] Celecoxib Ameliorates Portal Hypertension of the Cirrhotic Rats through the Dual Inhibitory Effects on the Intrahepatic Fibrosis and Angiogenesis

JH Gao, SL Wen, WJ Yang, YY Lu, H Tong… - PLoS …, 2013 - ui.adsabs.harvard.edu
Celecoxib Ameliorates Portal Hypertension of the Cirrhotic Rats through the Dual Inhibitory
Effects on the Intrahepatic Fibrosis and Angiogenesis - NASA/ADS Now on home page ads …
[PDF] researchgate.net

[PDF][PDF] Celecoxib Ameliorates Portal Hypertension of the Cirrhotic Rats through the Dual Inhibitory

JH Gao, SL Wen, WJ Yang, YY Lu, H Tong - 2013 - researchgate.net
Background: Increased intra-hepatic resistance to portal blood flow is the primary factor
leading to portal hypertension in cirrhosis. Up-regulated expression of cyclooxygenase-2 …
[PDF] psu.edu

[PDF][PDF] Celecoxib Ameliorates Portal Hypertension of the Cirrhotic Rats through the Dual Inhibitory

JH Gao, SL Wen, WJ Yang, YY Lu, H Tong - 2013 - Citeseer
Background: Increased intra-hepatic resistance to portal blood flow is the primary factor
leading to portal hypertension in cirrhosis. Up-regulated expression of cyclooxygenase-2 …

Celecoxib ameliorates portal hypertension of the cirrhotic rats through the dual inhibitory effects on the intrahepatic fibrosis and angiogenesis

JH Gao, SL Wen, WJ Yang, YY Lu, H Tong… - PloS …, 2013 - pubmed.ncbi.nlm.nih.gov
Background Increased intra-hepatic resistance to portal blood flow is the primary factor
leading to portal hypertension in cirrhosis. Up-regulated expression of cyclooxygenase-2 …